Aminoglycoside resistance in gram-negative blood isolates from various hospitals in Belgium and the Grand Duchy of Luxembourg

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 4, 1999, Pages 483-488

  Vanhoof, R ^a   Nyssen, H J ^a   Van Bossuyt, E ^a   Hannecart Pokorni, E ^a   Carpentier, M ^b   Delmee, M ^b   De Mol, P ^b   Garrino, M G ^b   Goosens, H ^b   Glupczynki, Y ^b   Hemmer, R ^b   Lauwers, S ^b   Meunier, F ^b   Struelens, M ^b   Van Landuyt, H ^b   Verbist, L ^b   Vershraegen, G ^b  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BACTERIAL ENZYME; GENTAMICIN; ISEPAMICIN; NETILMICIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BELGIUM; BLOOD CULTURE; ENTEROBACTERIACEAE; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE BACTERIUM; LUXEMBOURG; NONHUMAN; PERMEABILITY; POLYMERASE CHAIN REACTION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS;

EID: 0032833182     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.4.483     Document Type: Article

References (22)

1. Shimizu, K., Kumada, T., Hsieh, W.-C., Chung, H.-Y., Chong, Y., Hare, R. S. et al. (1985). Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrobial Agents and Chemotherapy 28, 282-8.
2. Dornbusch, K., Miller, G. H., Hare, R. S., Shaw, K. J. & the ESGAR Study Group. (1990). Resistance to aminoglycoside antibiotics in Gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. Journal of Antimicrobial Chemotherapy 26, 131-44.
3. Shaw, K. J., Hare, R. S., Sabatelli, F. J., Rizzo, M., Cramer, C. A., Naples, L. et al. (1991). Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrobial Agents and Chemotherapy 35, 2253-61.
4. Miller, G. H., Sabatelli, F. J., Hare, R. S., Glupczynski, Y., Mackey, P., Shlaes, D. et al. (1997). The most frequent aminoglycoside resistance mechanisms - changes with time and geographic area: a reflection of aminoglycoside usage patterns? Clinical Infectious Diseases 24, Suppl. 1, S46-S62.
5. Vanhoof, R., Godard, C., Nulens, E., Nyssen, H. J., Wildemauwe, C., Hubrechts, J. M. et al. (1993). Serotypes and extended spectrum β-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year survey. Journal of Hospital Infection 24, 129-38.
6. Busch-Sorensen, C., Sönmezoglu, M., Frimodt-Moller, N., Hojbjerg, T., Miller, G. H. & Espersen, F. (1996). Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used. APMIS 104, 763-8.
7. Vanhoof, R., Hubrechts, J. M., Nyssen, H. J. & Roebben, E. (1988). Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium. European Journal of Clinical Microbiology and Infectious Diseases 7, 183-5.
8. Maes, P. & Vanhoof, R. (1992). A 56-month prospective surveillance study on the epidemiology of aminoglycoside resistance in a Belgian general hospital. Scandinavian Journal of Infectious Diseases 24, 495-501.
9. Gerding, D. N., Larson, T. A., Hughes, R. A., Weiler, M., Shanholtzer, C. & Peterson, R. P. (1991). Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrobial Agents and Chemotherapy 35, 1284-90.
10. Friedland, I. R., Funk, E., Khoosal, M. & Klugman, K. P. (1992). Increased resistance to amikacin in a neonatal unit following intensive amikacin usage. Antimicrobial Agents and Chemotherapy 36, 1596-600.
11. King, J. W., White, M. C., Todd, J. R. & Conrad, S. A. (1992). Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. Clinical Infectious Diseases 14, 908-15.
12. Centrón Garcia, D., Catalano, M., Piñeiro, S., Woloj, M., Kaufman, S. & Sordelli, D. O. (1996). The emergence of resistance to amikacin in Serratia marcescens isolates from patients with nosocomial infection. International Journal of Antimicrobial Agents 7, 203-10.
13. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA.
14. National Committee for Clinical Laboratory Standards. (1997). Minimum Inhibitory Concentration (MIC) Interpretive Standards for Organisms other than Haemophilus spp., Neisseria gonorrhoeae, and Streptococcus spp. Document M100-S7, table 2. NCCLS, Wayne, PA.
15. Vanhoof, R., Content, J., Van Bossuyt, E., Nulens, E., Sonck, P., Depuydt, F. et al. (1993). Use of the polymerase chain reaction (PCR) for the detection of aacA genes encoding aminoglycoside-6′-N-acetyltransferases in reference strains and Gram-negative clinical isolates from two Belgian hospitals. Journal of Antimicrobial Chemotherapy 32, 23-35.
16. Hannecart-Pokorni, E., Depuydt, F., De Wit, L., van Bossuyt, E., Content, J. & Vanhoof, R. (1997). Characterization of the 6′-N-aminoglycoside acetyltransferase gene aac(6′)-ll associated with a sull-type integron. Antimicrobial Agents and Chemotherapy 41, 314-8.
17. Van Landuyt, H., Boelaert, J., Glibert, B., Gordts, B. & Verbruggen, A.-M. (1986). Surveillance of aminoglycoside resistance. European data. American Journal of Medicine 80, Suppl. 6B, 76-81.
18. Miller, G. H., Sabatelli, F. J., Naples, L., Hare, R. S. & Shaw, K. J. (1995). The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin - a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups. Journal of Chemotherapy 7, Suppl. 2, 31-44.
19. Caulin, E., Coutrot, A., Carbon, C. & Collatz, E. (1996). Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6′)-lb-bearing strain of Klebsiella pneumoniae susceptible in vitro. Antimicrobial Agents and Chemotherapy 40, 2848-53.
20. Mainardi, J.-L., Zhou, X. Y., Goldstein, F., Mohler, J., Farinotti, R., Gutmann, L. et al. (1994). Activity of isepamicin and selection of permeability mutants to β-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6′ modifying enzyme and a TEM-3 β-lactamase. Journal of Infectious Diseases 169, 1318-24.
21. Shaw, K. J., Sabatelli, F. J., Naples, L., Mann, P., Hare, R. S. & Miller, G. H. (1998). The application of molecular techniques for the study of aminoglycoside resistance. In Molecular Bacteriology: Protocols and Clinical Applications. Methods in Molecular Medicine 15, 555-77.
22. Aubry-Damon, H., Legrand, P., Brun-Buisson, C., Astier, A., Soussy, C.-J. & Leclercq, R. (1997). Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and change in aminoglycoside use. Clinical infectious Diseases 25, 647-53.